References
- Centers for Disease Control and Prevention. National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011
- Jankovec Z, Hahn M, Grunder S, et al. Analysis of continuous patient data from the Czech National Register of patients with type 1 and type 2 diabetes using insulin pump therapy. Diabetes Res Clin Pract 2010;87:219-23
- Gentry C, Cross B, Gross B, et al. Retrospective Analysis and Patient Satisfaction Assessment of Insulin Pump Therapy in Patients with Type 2 Diabetes. Southern Med J 2011;104:24-8
- Lynch P, Riedel A, Samant N. Improved A1C by switching to continuous subcutaneous insulin infusion from injection insulin therapy in type 2 diabetes; a retrospective claims analysis. Prim Care Diabetes 2010;4:209-14
- Wolff-McDonagh P, Kaufmann J, Foreman S, et al. Using insulin pump therapy in poorly controlled Type 2 Diabetes. Diabetes Educ 2010;36:657-65
- Herman WH, Ilag LL, Johnson SL, et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 2005;7:1568-73
- Reznik Y, Morera J, Rod A, et al. Efficacy of continuous subcutaneous insulin infusion in Type 2 Diabetes Mellitus: a survey on a cohort of 102 patients with prolonged follow-up. Diabetes Technol Ther 2010;12:931-6
- Wainstein J, Metzger M, Boaz M, et al. Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients. Diabet Med 2005;22:1037-46
- Rubin R, Peyrot M, Chen X, et al. Patient-reported outcomes from a 16-week open-label, multicenter study of insulin pump therapy in patients with Type 2 Diabetes Mellitus. Diabetes Technol Ther 2010;12:901-6
- Schwartz M. Health care reform and the primary care workforce bottleneck. J Gen Intern Med 2011;27:469-72
- Stewart A. The United States Endocrinology Workforce: a supply-demand mismatch. J Clin Endocrinol Metab 2008;93:1164-6
- Giberson S, Yoder S, Lee MP. Improving patient and health system outcomes through advanced pharmacy practice. A Report to the U.S. Surgeon General. Office of the Chief Pharmacist. Rockville, MD: U.S. Public Health Service, 2011
- Carter BL, Ardery G, Dawson JD, et al. Physician/pharmacist collaboration to improve blood pressure control. Arch Inter Med 2009;169:1996-2002
- Pape GA, Hunt JS, Butler KL, et al. Team-based care approach to cholesterol management in diabetes mellitus: two-year cluster randomized controlled trial. Arch Intern Med 2011;171:1480-6
- Ladhani NN, Majumdar SR, Johnson JA, et al. Adding pharmacists to primary care teams reduces predicted long-term risk of cardiovascular events in type 2 diabetic patients without established cardiovascular disease: results from a randomized trial. Diabet Med 2012;29:1433-9
- Simpson SH, Majumdar SR, Tsuyuki RT, et al. Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 2011;34:20-6
- Gilani F, Majumdar SR, Johnson JA, et al. Adding pharmacists to primary care teams increases guideline-concordant antiplatelet use in patients with type 2 diabetes: results from a randomized trial. Ann Pharmacother 2013;47:43-8
- Yu J, Shah BM, Ip E, et al. A Markov Model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California. J Manag Care Pharm 2013;19:102-14
- Rochester CD, Leon N, Dombrowski R, et al. Collaborative drug therapy management for initiating and adjusting insulin therapy in patients with type 2 diabetes mellitus. Am J Health Syst Pharm 2010;67:42-8
- Nkansah NT, Brewer JM, Connors R, et al. Clinical outcomes of patients with diabetes mellitus receiving medication management by pharmacists in an urban private physician practice. Am J Health Syst Pharm 2008;65:145-9
- Kiel PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother 2005;39:1828-32
- Lepore G, Bruttomesso D, Bonomo M, et al. Continuous subcutaneous insulin infusion is more effective than multiple daily injections in preventing albumin excretion rate increase in Type 1 diabetic patients. Diabet Med 2009;26:602-8